1. Vishnubalaji, Radhakrishnan, Alajez, Nehad M. 2021. Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq. In Molecular therapy oncolytics, 23, 151-162. doi:10.1016/j.omto.2021.09.002. https://pubmed.ncbi.nlm.nih.gov/34703883/
2. Levshenkova, E V, Ukraintsev, K E, Orlova, V V, Zhugdernamzhilyn, O, Frolova, E I. . [The structure and specific features of the cDNA expression of the human gene MRPL37]. In Bioorganicheskaia khimiia, 30, 499-506. doi:. https://pubmed.ncbi.nlm.nih.gov/15562971/
3. Du, Wenlong, Yu, Shihui, Liu, Ruiyao, Hao, Xin, Liu, Yi. 2025. Precision Prediction of Alzheimer's Disease: Integrating Mitochondrial Energy Metabolism and Immunological Insights. In Journal of molecular neuroscience : MN, 75, 5. doi:10.1007/s12031-024-02291-7. https://pubmed.ncbi.nlm.nih.gov/39806062/
4. Wang, Xu, Li, Sainan, Shen, Yuhuan, Yang, Jiyun, Wang, Tongtong. 2024. Construction of molecular subtype and prognostic model for gastric cancer based on nucleus-encoded mitochondrial genes. In Scientific reports, 14, 28491. doi:10.1038/s41598-024-78729-0. https://pubmed.ncbi.nlm.nih.gov/39557952/
5. Sundquist, Kristina, Ahmad, Abrar, Svensson, Peter J, Sundquist, Jan, Memon, Ashfaque A. . Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner. In Journal of thrombosis and thrombolysis, 46, 154-165. doi:10.1007/s11239-018-1662-x. https://pubmed.ncbi.nlm.nih.gov/29671165/
智鼠故事 
